Skip to main content
Clinical Trials/CTRI/2021/04/032610
CTRI/2021/04/032610
Completed
未知

Comparative therapeutic efficacy of intralesional bleomycin and intralesional vitamin D-3 in verruca vulgaris.

Department of Dermatology Venereology and Leprosy0 sites32 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of Dermatology Venereology and Leprosy
Enrollment
32
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
September 1, 2022
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Department of Dermatology Venereology and Leprosy

Eligibility Criteria

Inclusion Criteria

  • 1\. All untreated consecutive patients having single/ multiple lesions of verruca vulgaris.
  • 2\. Patients above the age of 14 years.

Exclusion Criteria

  • 1\. Pregnant or lactating females.
  • 2\. Immunocompromised individuals including HIV.
  • 3\. Patients known to have hypersensitivity to vitamin D\-3\.
  • 4\. Patients having history of peripheral vascular disorders like scleroderma or Raynaudââ?¬•s phenomenon.
  • 5\. Patients with pulmonary fibrosis.
  • 6\. History of intake of vitamin D\-3, anabolic steroids, bisphosphonates in the last 3 months or history of intravenous chemotherapy with bleomycin in the past.
  • 7\. Patients having any significant systemic illness.

Outcomes

Primary Outcomes

Not specified

Similar Trials